The anticoagulant effects of milvexian, a novel small molecule factor XIa inhibitor, are neutralized by activated prothrombin complex concentrates and recombinant factor VIIa in human plasma and whole blood in vitro. [PDF]
Res Pract Thromb HaemostBunce M, Huang Devine Z, Chintala M.
europepmc +1 more source
Japanese Journal of Thrombosis and Hemostasis, 2009 Mitsuhiro KUWAHARA, Morio ARAI
openaire +2 more sources
CT-001, a novel fast-clearing factor VIIa, enhanced the hemostatic activity in postpartum samples. [PDF]
Blood AdvSim DS +8 more
europepmc +1 more source
Therapeutic doses of recombinant factor VIIa in hemophilia generates thrombin in platelet-dependent and -independent mechanisms. [PDF]
J Thromb Haemost, 2020 Keshava S +3 more
europepmc +1 more source
Use of Factor VIIa and Anti-inhibitor Coagulant Complex in Pediatric Cardiac Surgery Patients. [PDF]
J Pediatr Pharmacol Ther, 2020 Carroll RB +4 more
europepmc +1 more source
Recombinant Factor VIIa : A Universal Haemostatic Agent?
Annals of Cardiac Anaesthesia, 2006 Gill R, Herbertson M
doaj
MicroRNA-10a enrichment in factor VIIa-released endothelial extracellular vesicles: potential mechanisms. [PDF]
J Thromb HaemostDas K +4 more
europepmc +1 more source
The evolution of factor VIIa in the treatment of bleeding in haemophilia with inhibitors. [PDF]
Haemophilia, 2019 Meeks SL, Leissinger CA.
europepmc +1 more source
Beating tissue factor at its own game: Design and properties of a soluble tissue factor-independent coagulation factor VIIa. [PDF]
J Biol Chem, 2020 Sorensen AB +7 more
europepmc +1 more source